Polyisoprenylated methylated protein methyl esterase as a putative drug target for androgen-insensitive prostate cancer

Prostate cancer (CaP) is the most frequently diagnosed cancer in US men, with an estimated 236,590 new cases and 29,720 deaths in 2013. There exists the need to identify biomarkers/therapeutic targets for the early/companion diagnosis and development of novel therapies against the recalcitrant disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Poku, Rosemary A, Amissah, Felix, Duverna, Randolph, Aguilar, Byron J, Kiros, Gebre-Egziabher, Lamango, Nazarius S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154947/
https://www.ncbi.nlm.nih.gov/pubmed/25228915
http://dx.doi.org/10.3332/ecancer.2014.459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154947/
https://www.ncbi.nlm.nih.gov/pubmed/25228915
http://dx.doi.org/10.3332/ecancer.2014.459

Ejemplares similares